Medical Sales jobs, a return to old.

Monday Nov 20

The pharmaceutical industry is changing it's approach, and with it comes a need for a different approach to Medical sales and the structure of pharmaceutical jobs.

Pharmaceutical jobs have never been more volatile. Companies are merging or buying on a weekly basis, medical sales forces are appearing and dispanding on a weekly basis, so what does the future hold.

A primary cause lies in the increased risk of bringing products to market. It was always a lengthy, costly and risky process. The risk is now heightened by the uncertainty presented by NICE following the launch of new drugs.

The buddy rep system for medical sales operated by many of the pharmaceutical industry's larger players was very much a strategy aimed at medium or even long term profits. Given the increased risks, this is no longer an acceptable scenario, shareholders want to see profit now. Consequently, the days of the buddy rep may be numbered. already, many pharmaceutical companies are returning to the more profitable 'one rep per territory', creating a more accountable, and of course, more profitable role. It's good news for pharmaceutical sales people who want to be accountable for there results, but obviously bad news with regard to the over all size of the medical sales community.